[1]
Sourik Shee, “Suzetrigine: A First-in-Class NaV1.8 Inhibitor – Mechanism and Clinical Trial Evidence for Acute Pain”, APJHS, vol. 13, no. 3, pp. 87–92, Aug. 2026.